Trending:
News
-
16 January 2019
US Oversight Committee launches drug price probe into major companies
The US Committee on Oversight and Reform chairman Elijah Cummings has launched an investigation into the drug pricing practices of multiple pharmaceutical companies.
-
16 January 2019
Eisai and Purdue Pharma seek US approval for lemborexant to treat insomnia
Eisai and its partner Purdue Pharma have submitted new drug application to the US Food and Drug Administration (FDA) seeking approval for lemborexant to treat insomnia, a sleep disorder.
-
16 January 2019
Sanofi and Biomunex partner to develop antibody therapeutics
Sanofi has signed a licensing agreement with French biopharmaceutical firm Biomunex Pharmaceuticals for the development of antibody-based drugs.
-
15 January 2019
Ascletis Pharma to develop Alphamab’s viral diseases drug in China
Ascletis Pharma has signed an exclusive licensing agreement with Suzhou Alphamab to develop an investigational candidate, KN035, for the treatment of viral diseases such as hepatitis B in Greater China.
-
15 January 2019
FDA agrees to review Pfizer’s NDAs for tafamidis
The US Food and Drug Administration (FDA) has accepted Pfizer’s two new drug applications (NDAs) for tafamidis to treat transthyretin amyloid cardiomyopathy (ATTR-CM).
-
14 January 2019
Knight Therapeutics licences cancer drug from Puma Biotechnology
Canada-based Knight Therapeutics signed an exclusive licence agreement with Puma Biotechnology to commercialise Nerlynx (neratinib) medicine in the country.
-
14 January 2019
UK and Japan partner on treatments for degenerative diseases
Medical researchers in the UK and Japan are set to work together on advancing research aimed at developing treatments for chronic degenerative and incurable diseases, including diabetes and heart disease.
-
14 January 2019
Global Fund seeks $14bn to fight AIDS, TB and malaria
An international health fund that finances the fight against acquired immune deficiency syndrome (AIDS), tuberculosis (TB) and malaria has announced a $14bn fundraising target for the next three years to...
-
11 January 2019
Sumitomo Dainippon announces good results from trial of its lead drug
Japan-based Sumitomo Dainippon Pharma has published positive results from the phase III JEWEL trial into its drug Latuda (lurasidone hydrochloride) for patients with schizophrenia.
-
11 January 2019
US lawmakers to introduce new bills to slash prescription drug prices
US Senator Bernie Sanders and Representative Elijah Cummings have announced plans to introduce three new bills to reduce the price of prescription drugs in the country.